The checkpoint kinase ATM protects against stress-induced elevation of cyclin D1 and potential cell death in neurons

Cytometry Part A

Volumn 77, Issue 6, 2010, Pages 524-533

  Hitomi, Masahiro ^a   Stacey, Dennis W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Ataxia telangiectasia; ATM; Cell cycle; Cyclin D1; Neural stem cell; Neurodegeneration; Neuron; Reactive oxygen

Indexed keywords

ATM PROTEIN; CELL CYCLE PROTEIN; CYCLIN D1; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; ATAXIA TELANGIECTASIA; CELL DEATH; CELL LINE; CYTOLOGY; DOWN REGULATION; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; NERVE CELL; OXIDATIVE STRESS;

ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE; CYCLIN D1; DNA-BINDING PROTEINS; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; NEURONS; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 77952722363     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20885     Document Type: Article

References (37)

1. McKinnon PJ. ATM and ataxia telangiectasia. EMBO Rep 2004;5:772-776.
2. Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001;15:2177-2196.
3. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;421:499-506.
4. Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 2004;5:792-804.
5. Shiloh Y. The ATM-mediated DNA-damage response: Taking shape. Trends Biochem Sci 2006;31:402-410.
6. Lavin MF, Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007;6:931-942.
7. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-1753.
8. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995;4:2025-2032.
9. Onodera O. Spinocerebellar ataxia with ocular motor apraxia and DNA repair. Neuropathology 2006;26:361-367.
10. Frappart PO, McKinnon PJ. Ataxia-telangiectasia and related diseases. Neuromolecular Med 2006;8:495-511.
11. Biton S, Barzilai A, Shiloh Y. The neurological phenotype of ataxia-telangiectasia: Solving a persistent puzzle. DNA Repair (Amst) 2008;7:1028-1038.
12. Vincent I, Rosado M, Davies P. Mitotic mechanisms in Alzheimer's disease? J Cell Biol 1996;132:413-425.
13. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 1997;150:1933-1939.
14. Delobel P, Lavenir I, Ghetti B, Holzer M, Goedert M. Cell-cycle markers in a transgenic mouse model of human tauopathy: Increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1. Am J Pathol 2006;168:878-887.
15. Arendt T, Rodel L, Gartner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 1996;7:3047-3049.
16. Bhaskar K, Miller M, Chludzinski A, Herrup K, Zagorski M, Lamb BT. The PI3KAkt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events. Mol Neurodegener 2009;4:1-18.
17. Herrup K, Yang Y. Cell cycle regulation in the postmitotic neuron: Oxymoron or new biology? Nat Rev Neurosci 2007;8:368-378.
18. Kranenburg O, van der Eb AJ, Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. Embo J 1996;15:46-54.
19. Ino H, Chiba T. Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo. J Neurosci 2001;21:6086-6094.
20. Koeller HB, Ross ME, Glickstein SB. Cyclin D1 in excitatory neurons of the adult brain enhances kainate-induced neurotoxicity. Neurobiol Dis 2008;31:230-241.
21. Pagano M, Theodoras AM, Tam SW, Draetta GF. Cycling D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblassts. Genes Dev 1994;8:1627-1639.
22. Guo Y, Yang K, Harwalkar J, Nye JM, Mason DR, Garrett MD, Hitomi M, Stacey DW. Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 2005;24:2599-2612.
23. Guo Y, Harwalkar J, Stacey DW, Hitomi M. Destabilization of cyclin D1 message plays a critical role in cell cycle exit upon mitogen withdrawal. Oncogene 2005;24:1032-1042.
24. Hitomi M, Stacey DW. Cyclin D1 production in cycling cells depends on ras in a cellcycle-specific manner. Curr Biol 1999;9:1075-1084. (Pubitemid 29504477)
25. Hitomi M, Stacey DW. Cellular ras and cyclin D1 are required during different cell cycle periods in cycling NIH 3T3 cells. Mol Cell Biol 1999;19:4623-4632.
26. Hitomi M, Stacey DW. Ras-dependent cell cycle commitment during G2 phase. FEBS Lett 2001;490:123-131.
27. Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 2003;15:158-163.
28. Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitom M, Stacey DW. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. BMC Cell Biol 2006;7:33-52.
29. Yang K, Hitomi M, Stacey DW. Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div 2006;1:32-40.
30. Petermann E, Caldecot KW. Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 2006;5:2203-2209.
31. Hitomi M, Yang K, Stacey AW, Stacey DW. Phosphorylation of cyclin D1 regulated by ATM or ATR controls cell cycle progression. Mol Cell Biol 2008;28:5478-5493.
32. Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GC. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 2004;64:9152-9159.
33. Stacey DW, Hitomi M Cell cycle studies based upon quantitative image analysis. Cytometry A 2008;73A:270-278.
34. Yang Y, Herrup K. Loss of neuronal cell cycle control in ataxia-telangiectasia: A unified disease mechanism. J Neurosci 2005;25:2599-12529
35. Barzilai A, Biton S, Shiloh Y. The role of the DNA damage response in neuronal development, organization and maintenance. DNA Repair (Amst) 2008;7:1010-1027.
36. Barzilai A, Yamamoto. K. DNA damage responses to oxidative stress. DNA Repair (Amst) 2004;3:1109-1115.
37. Varvel NH, Bhaskar K, Kounnas MZ, Wagner SL, Yang Y, Lamb BT, Herrup K. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest 2009;119:3692-3702.